The recent findings of Waldo et al. 1 demonstrate that the fusion of the green fluorescent protein (GFP) to insoluble proteins dramatically reduces its folding ability in prokaryotic cells.

Explore ESM3's groundbreaking AI technology in protein design, offering new possibilities in drug discovery and material ...

Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a ...

RNAs have been shown to have a function in protein secretion after thousands more binding targets were identified using a ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

Avoid fusions to the GFP fragments at the site of protein-protein interaction and consider optimizing the spacer length between the fusions and GFP fragments, if necessary. In the absence of ...

Using this model, the researchers generated proteins with mutations that were predicted to lead to improved versions of GFP ...

The researchers introduced green fluorescent protein (GFP) into the dsx sequence so that GFP was produced together with the dsx protein. The neuronal circuits could then be viewed using ...

One of the most notable applications of bioluminescence in research involves the use of bioluminescent proteins, such as Green Fluorescent Protein (GFP), in genetic and cellular studies.

Synthetic variants of a green fluorescent protein To demonstrate the performance of ESM3, the start-up had the language model design synthetic variants of the green fluorescent protein (GFP ...

tau Proteins, MGC138549, FLJ31424 Number of Launched Drugs: 1 Number of Drugs in Clinical Trials: 34 Lastest Research Phase: Approved FACS study of Tau-K18 (GFP) in the stable cell line HEK293 ...